<DOC>
	<DOC>NCT00448175</DOC>
	<brief_summary>The purpose of this study is to compare percutaneous tibial nerve stimulation (PTNS) to drug therapy for the treatment of symptoms of overactive bladder (OAB).</brief_summary>
	<brief_title>Overactive Bladder Innovative Therapy Trial (OrBIT)</brief_title>
	<detailed_description />
	<mesh_term>Urinary Bladder, Overactive</mesh_term>
	<mesh_term>Tolterodine Tartrate</mesh_term>
	<criteria>Is at least 18 years of age Experiences OAB with a voiding frequency of at least 8 times per day Is ambulatory and able to use a toilet independently and without difficulty On OAB pharmacotherapy within the previous month Primary complaint is stress urinary incontinence Has pacemaker or implantable defibrillator Has history of heart problems Has nerve damage or neuropathy Has gastric or urinary retention Has uncontrolled narrowangle glaucoma Has known sensitivity to drug ingredients Is pregnant or planning to become pregnant during the trial</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>April 2013</verification_date>
	<keyword>OAB symptoms of urgency, frequency, and urge incontinence</keyword>
</DOC>